SOTERA HEALTH COMPANY Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2023-11-01: Disclosure Rule10b51Arr Adopted; Period 2023-07-01..2023-09-30; Value No.
- 2023-11-01: Disclosure Non Rule10b51Arr Adopted; Period 2023-07-01..2023-09-30; Value No.
- 2023-11-01: Disclosure Rule10b51Arr Terminated; Period 2023-07-01..2023-09-30; Value No.
- 2023-11-01: Disclosure Non Rule10b51Arr Terminated; Period 2023-07-01..2023-09-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2023-11-01 10-Q | Rule10b51Arr Adopted | 2023-07-01..2023-09-30 | No | |
| 2023-11-01 10-Q | Non Rule10b51Arr Adopted | 2023-07-01..2023-09-30 | No | |
| 2023-11-01 10-Q | Rule10b51Arr Terminated | 2023-07-01..2023-09-30 | No | |
| 2023-11-01 10-Q | Non Rule10b51Arr Terminated | 2023-07-01..2023-09-30 | No | |
| 2023-08-03 10-Q | Non Rule10b51Arr Adopted | 2023-04-01..2023-06-30 | No | |
| 2023-08-03 10-Q | Rule10b51Arr Adopted | 2023-04-01..2023-06-30 | No | |
| 2023-08-03 10-Q | Rule10b51Arr Terminated | 2023-04-01..2023-06-30 | No | |
| 2023-08-03 10-Q | Non Rule10b51Arr Terminated | 2023-04-01..2023-06-30 | No | |
| 2023-04-13 DEF 14A | Pay versus Performance Table | 2022-01-01..2022-12-31 | PAY VERSUS PERFORMANCE Pay versus Performance Table The following section has been prepared in accordance with the SEC’s new rules requiring annual disclosure of pay-versus-performance (“PvP”) which shows the relationship between executive compensation actually paid (“CAP”) and the Company’s perform… | |
| 2023-04-13 DEF 14A | Named Executive Officers Footnote | 2022-01-01..2022-12-31 | 3. The following non-CEO NEOs are included in the average figures shown: • 2020: Michael Rutz, Scott Leffler • 2021: Michael Rutz, Scott Leffler, Terrence Hammons, Matthew Klaben. • 2022: Michael Rutz, Scott Leffler, Terrence Hammons, Matthew Klaben, Alexander Dimitrief, Michael Biehl | |
| 2023-04-13 DEF 14A | Peer Group Issuers Footnote | 2022-01-01..2022-12-31 | Represents the cumulative TSR of the S&P 500 Healthcare Index (i) for 2020, over the one-year period from market close December 31, 2019 through December 31, 2020, (ii) for 2021, over the two-year period from market close on December 31, 2019 through December 31, 2021, (iii) and for 2022, ov… | |
| 2023-04-13 DEF 14A | Adjustment To PEO Compensation Footnote | 2022-01-01..2022-12-31 | The tables below disclose the amounts deducted from, and added to, the Summary Compensation Table total compensation amounts to calculate the Compensation Actually Paid for each of the applicable years, for the CEO and average non-CEO NEOs, as shown in columns (c) and (e) of the PvP Table, respectiv… | |
| 2023-04-13 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2022-01-01..2022-12-31 | The tables below disclose the amounts deducted from, and added to, the Summary Compensation Table total compensation amounts to calculate the Compensation Actually Paid for each of the applicable years, for the CEO and average non-CEO NEOs, as shown in columns (c) and (e) of the PvP Table, respectiv… | |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: StockAwardAndOptionAwardValuesReportedInSummaryCompensationTableForTheCoveredYear; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$14.46M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueForStockAndOptionAwardsGrantedInTheCoveredYear; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $13.02M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYears; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$5.93M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInTheCoveredYear; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$3.38M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueOfStockAndOptionAwardsForfeitedDuringTheCoveredYear; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: StockAwardAndOptionAwardValuesReportedInSummaryCompensationTableForTheCoveredYear; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueForStockAndOptionAwardsGrantedInTheCoveredYear; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYears; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | -$3.17M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInTheCoveredYear; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | -$1.39M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueOfStockAndOptionAwardsForfeitedDuringTheCoveredYear; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: StockAwardAndOptionAwardValuesReportedInSummaryCompensationTableForTheCoveredYear; ExecutiveCategory: Peo | 2020-01-01..2020-12-31 | -$15.00M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueForStockAndOptionAwardsGrantedInTheCoveredYear; ExecutiveCategory: Peo | 2020-01-01..2020-12-31 | $20.22M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYears; ExecutiveCategory: Peo | 2020-01-01..2020-12-31 | $0.00 |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInTheCoveredYear; ExecutiveCategory: Peo | 2020-01-01..2020-12-31 | $0.00 |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueOfStockAndOptionAwardsForfeitedDuringTheCoveredYear; ExecutiveCategory: Peo | 2020-01-01..2020-12-31 | $0.00 |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: StockAwardAndOptionAwardValuesReportedInSummaryCompensationTableForTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$1.25M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueForStockAndOptionAwardsGrantedInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $948.45K |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYears; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$1.15M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$268.00K |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueOfStockAndOptionAwardsForfeitedDuringTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$1.16M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: StockAwardAndOptionAwardValuesReportedInSummaryCompensationTableForTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | -$125.00K |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueForStockAndOptionAwardsGrantedInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $139.45K |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYears; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | -$991.45K |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | -$471.56K |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueOfStockAndOptionAwardsForfeitedDuringTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: StockAwardAndOptionAwardValuesReportedInSummaryCompensationTableForTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2020-01-01..2020-12-31 | -$4.35M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueForStockAndOptionAwardsGrantedInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2020-01-01..2020-12-31 | $10.97M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfOutstandingUnvestedStockAndOptionAwardsFromPriorYears; ExecutiveCategory: NonPeoNeo | 2020-01-01..2020-12-31 | $2.39M |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfStockAndOptionAwardsFromPriorYearsThatVestedInTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2020-01-01..2020-12-31 | $80.14K |
| 2023-04-13 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueOfStockAndOptionAwardsForfeitedDuringTheCoveredYear; ExecutiveCategory: NonPeoNeo | 2020-01-01..2020-12-31 | $0.00 |
| 2023-04-13 DEF 14A | Tabular List Table | 2022-01-01..2022-12-31 | The following financial performance measures represent, in the Company’s assessment, the most important financial measures the Company used to link compensation that we actually paid to our named executive officers for 2022: Financial Performance Metrics Adjusted EBITDA Sterigenics Segment Income | |
| 2023-04-13 DEF 14A | Non Gaap Measure Description | Measure: 1 | 2022-01-01..2022-12-31 | The Company’s Annual Reports on Form 10-K for the years ended on December 31 for each of 2022, 2021 and 2020, include additional information on the calculation of Adjusted EBITDA and Sterigenics Segment Income, including non-GAAP reconciliation information. |
| 2023-04-13 DEF 14A | Compensation Actually Paid Vs Company Selected Measure | 2022-01-01..2022-12-31 | ||
| 2023-04-13 DEF 14A | Compensation Actually Paid Vs Net Income | 2022-01-01..2022-12-31 | ||
| 2023-04-13 DEF 14A | Compensation Actually Paid Vs Total Shareholder Return | 2022-01-01..2022-12-31 | ||
| 2023-04-13 DEF 14A | Total Shareholder Return Vs Peer Group | 2022-01-01..2022-12-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |